548 related articles for article (PubMed ID: 34163069)
1. Phase separation drives aberrant chromatin looping and cancer development.
Ahn JH; Davis ES; Daugird TA; Zhao S; Quiroga IY; Uryu H; Li J; Storey AJ; Tsai YH; Keeley DP; Mackintosh SG; Edmondson RD; Byrum SD; Cai L; Tackett AJ; Zheng D; Legant WR; Phanstiel DH; Wang GG
Nature; 2021 Jul; 595(7868):591-595. PubMed ID: 34163069
[TBL] [Abstract][Full Text] [Related]
2. CREB binding protein interacts with nucleoporin-specific FG repeats that activate transcription and mediate NUP98-HOXA9 oncogenicity.
Kasper LH; Brindle PK; Schnabel CA; Pritchard CE; Cleary ML; van Deursen JM
Mol Cell Biol; 1999 Jan; 19(1):764-76. PubMed ID: 9858599
[TBL] [Abstract][Full Text] [Related]
3. Phase Separation Mediates NUP98 Fusion Oncoprotein Leukemic Transformation.
Chandra B; Michmerhuizen NL; Shirnekhi HK; Tripathi S; Pioso BJ; Baggett DW; Mitrea DM; Iacobucci I; White MR; Chen J; Park CG; Wu H; Pounds S; Medyukhina A; Khairy K; Gao Q; Qu C; Abdelhamed S; Gorman SD; Bawa S; Maslanka C; Kinger S; Dogra P; Ferrolino MC; Di Giacomo D; Mecucci C; Klco JM; Mullighan CG; Kriwacki RW
Cancer Discov; 2022 Apr; 12(4):1152-1169. PubMed ID: 34903620
[TBL] [Abstract][Full Text] [Related]
4. NUP98 fusion in human leukemia: dysregulation of the nuclear pore and homeodomain proteins.
Nakamura T
Int J Hematol; 2005 Jul; 82(1):21-7. PubMed ID: 16105755
[TBL] [Abstract][Full Text] [Related]
5. Chromatin-prebound Crm1 recruits Nup98-HoxA9 fusion to induce aberrant expression of Hox cluster genes.
Oka M; Mura S; Yamada K; Sangel P; Hirata S; Maehara K; Kawakami K; Tachibana T; Ohkawa Y; Kimura H; Yoneda Y
Elife; 2016 Jan; 5():e09540. PubMed ID: 26740045
[TBL] [Abstract][Full Text] [Related]
6. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
[TBL] [Abstract][Full Text] [Related]
7. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
Calvo KR; Sykes DB; Pasillas MP; Kamps MP
Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
[TBL] [Abstract][Full Text] [Related]
8. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
[TBL] [Abstract][Full Text] [Related]
9. NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis.
Wang GG; Cai L; Pasillas MP; Kamps MP
Nat Cell Biol; 2007 Jul; 9(7):804-12. PubMed ID: 17589499
[TBL] [Abstract][Full Text] [Related]
10. Leukemogenic mechanisms and targets of a NUP98/HHEX fusion in acute myeloid leukemia.
Jankovic D; Gorello P; Liu T; Ehret S; La Starza R; Desjobert C; Baty F; Brutsche M; Jayaraman PS; Santoro A; Mecucci C; Schwaller J
Blood; 2008 Jun; 111(12):5672-82. PubMed ID: 18388181
[TBL] [Abstract][Full Text] [Related]
11. Single-translocation and double-chimeric transcripts: detection of NUP98-HOXA9 in myeloid leukemias with HOXA11 or HOXA13 breaks of the chromosomal translocation t(7;11)(p15;p15).
Fujino T; Suzuki A; Ito Y; Ohyashiki K; Hatano Y; Miura I; Nakamura T
Blood; 2002 Feb; 99(4):1428-33. PubMed ID: 11830496
[TBL] [Abstract][Full Text] [Related]
12. Expression of Leukemia-Associated Nup98 Fusion Proteins Generates an Aberrant Nuclear Envelope Phenotype.
Fahrenkrog B; Martinelli V; Nilles N; Fruhmann G; Chatel G; Juge S; Sauder U; Di Giacomo D; Mecucci C; Schwaller J
PLoS One; 2016; 11(3):e0152321. PubMed ID: 27031510
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of CRM1-mediated nuclear export of transcription factors by leukemogenic NUP98 fusion proteins.
Takeda A; Sarma NJ; Abdul-Nabi AM; Yaseen NR
J Biol Chem; 2010 May; 285(21):16248-57. PubMed ID: 20233715
[TBL] [Abstract][Full Text] [Related]
14. Amino-terminal enhancer of split (AES) interacts with the oncoprotein NUP98-HOXA9 and enhances its transforming ability.
Sarma NJ; Yaseen NR
J Biol Chem; 2011 Nov; 286(45):38989-9001. PubMed ID: 21937451
[TBL] [Abstract][Full Text] [Related]
15. Major form of NUP98/HOXC11 fusion in adult AML with t(11;12)(p15;q13) translocation exhibits aberrant trans-regulatory activity.
Gu BW; Wang Q; Wang JM; Xue YQ; Fang J; Wong KF; Chen B; Shi ZZ; Shi JY; Bai XT; Wu DH; Chen Z; Chen SJ
Leukemia; 2003 Sep; 17(9):1858-64. PubMed ID: 12970787
[TBL] [Abstract][Full Text] [Related]
16. NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.
Gough SM; Slape CI; Aplan PD
Blood; 2011 Dec; 118(24):6247-57. PubMed ID: 21948299
[TBL] [Abstract][Full Text] [Related]
17. Through the lens of phase separation: intrinsically unstructured protein and chromatin looping.
Cai L; Wang GG
Nucleus; 2023 Dec; 14(1):2179766. PubMed ID: 36821650
[TBL] [Abstract][Full Text] [Related]
18. Dynein Light Chain 1 (DYNLT1) Interacts with Normal and Oncogenic Nucleoporins.
Sarma NJ; Yaseen NR
PLoS One; 2013; 8(6):e67032. PubMed ID: 23840580
[TBL] [Abstract][Full Text] [Related]
19. The oncogene Nup98-HOXA9 induces gene transcription in myeloid cells.
Ghannam G; Takeda A; Camarata T; Moore MA; Viale A; Yaseen NR
J Biol Chem; 2004 Jan; 279(2):866-75. PubMed ID: 14561764
[TBL] [Abstract][Full Text] [Related]
20. Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression.
Terlecki-Zaniewicz S; Humer T; Eder T; Schmoellerl J; Heyes E; Manhart G; Kuchynka N; Parapatics K; Liberante FG; Müller AC; Tomazou EM; Grebien F
Nat Struct Mol Biol; 2021 Feb; 28(2):190-201. PubMed ID: 33479542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
